DYD B-11
LqbjbTbNhSyhKZUQTx 112
Thanks for calling http://xtube.in.net xtube  "Given the negative panel vote, we do not expect an approval on the December 20 (review) date and see this outcome as a significant setback for Vascepa's commercial outlook," J.P. Morgan Securities analyst Chris Schott wrote in a note.
Dexter 2019-05-26 17:11:04

ȸ»ç¼Ò°³ | ã¾Æ¿À½Ã´Â ±æ | ÀÎÁõ³»¿ëº¸±â